激活素A(ACVA)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)
CLIA Kit for Activin A (ACVA)
ACV-A; Activin Beta A Beta A Homodimer
- 編號(hào)SCA001Hu
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)2h, 40min
- 檢測(cè)范圍1.37-1,000pg/mL
- 靈敏度最小可檢測(cè)劑量小于等于0.49pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格48T96T96T*596T*1096T*100
- 價(jià)格¥ 3528¥ 5040¥ 22680¥ 42840¥ 352800
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
實(shí)驗(yàn)結(jié)果圖
標(biāo)準(zhǔn)曲線圖
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
本試劑盒用于檢測(cè)激活素A(ACVA)，經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制，不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè)，因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的激活素A(ACVA)（加標(biāo)樣品），重復(fù)測(cè)定并計(jì)算其均值，回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 86-96 | 92 |
| EDTA plasma(n=5) | 97-105 | 101 |
| heparin plasma(n=5) | 97-105 | 102 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差：取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次，分別計(jì)算不同濃度樣本的平均值及SD值。
批間差：選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定，每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次，分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的激活素A(ACVA)，并倍比稀釋成1:2，1:4，1:8，1:16的待測(cè)樣本，線性范圍即為稀釋后樣本中激活素A(ACVA)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 98-105% | 92-103% | 87-101% | 96-105% |
| EDTA plasma(n=5) | 80-93% | 88-95% | 78-92% | 99-105% |
| heparin plasma(n=5) | 89-102% | 82-104% | 92-99% | 83-97% |
穩(wěn)定性
經(jīng)測(cè)定，試劑盒在有效期內(nèi)按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響，實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致，尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備；
2. 加樣（標(biāo)準(zhǔn)品及樣本）100µL，37°C孵育1小時(shí)；
3. 吸棄，加檢測(cè)溶液A100μL，37°C孵育1小時(shí)；
4. 洗板3次；
5. 加檢測(cè)溶液B100µL，37°C孵育30分鐘；
6. 洗板5次；
7. 加底物100µL，37°C孵育10分鐘；
8. 讀數(shù)。
實(shí)驗(yàn)原理
將激活素A(ACVA)抗體包被于96孔微孔板中，制成固相載體，向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本，其中的激活素A(ACVA)與連接于固相載體上的抗體結(jié)合，然后加入生物素化的激活素A(ACVA)抗體，將未結(jié)合的生物素化抗體洗凈后，加入HRP標(biāo)記的親和素，再次徹底洗滌后加入底物。加入底物后會(huì)產(chǎn)生輝光型光信號(hào)。發(fā)射光強(qiáng)度和樣品中的激活素A(ACVA)呈正相關(guān)。用化學(xué)發(fā)光儀測(cè)定相對(duì)光單位（RLU），計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA001Hu01 | 激活素A(ACVA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA001Hu01 | 激活素A(ACVA)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA001Hu01 | 激活素A(ACVA)多克隆抗體 | WB; ICC; IHC-P; IHC-F; ELISA. |
| SEA001Hu | 激活素A(ACVA)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CEA001Hu | 激活素A(ACVA)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA001Hu | 激活素A(ACVA)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA001Hu | 激活素A(ACVA)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| 13 | Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction[Ahajournals: Source] |
| J. Pharmacogn | [Article: Hksobf_2015_V46N2_167] |
| United States Patent Application | Methods for Diagnosis and Treatment of Concussion or Brain Injury[2016:0103140] |
| BMC Cancer. | Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer.[pubmed:27835986] |
| Basic Clin Pharmacol Toxicol. | Magnolol Attenuates Concanavalin A-induced Hepatic Fibrosis, Inhibits CD4+ T Helper 17 (Th17) Cell Differentiation and Suppresses Hepatic Stellate Cell Activation: Blockade of Smad3/Smad4 Signalling.[pubmed:28032440] |
| Basic & Clinical Pharmacology & Toxicology | Magnolol Attenuates Concanavalin A-induced Hepatic Fibrosis, Inhibits CD4 + T Helper 17(Th17) Cell Differentiation and Suppresses Hepatic Stellate Cell Activation: Blockade of Smad3/Smad4 Signalling[doi:10.1111] |
| Journal of Immunology | MicroRNA-27b Modulates Inflammatory Response and Apoptosis during Mycobacterium tuberculosis Infection[Pubmed:29661829] |
| Journal of?Vascular?Surgery | Expression of platelet-derived growth factor B is upregulated in patients with thoracic aortic dissection[Pubmed:29685513] |
| Acta Biochimica et Biophysica Sinica | Toxic effects of arsenic trioxide on protoscoleces through ROS production, and Ca-ER stress-dependent apoptosis[10.1093:abbs] |
| Poultry?Science | The effect of raw and fermented rapeseed cake on the metabolic parameters, immune status, and intestinal morphology of turkeys[Pubmed:29917099] |
| Food Bioscience | Characterization of Phospholipids from Pacific Saury () Viscera and Their Neuroprotective Activity[10.1016:j.fbio.2018.06.002] |
| Current Analytical Chemistry | Single Wall Carbon Nanotube and Magnetic Bead Based Electrochemical Immunosensor for Sensitive Detection of Salivary Secretory Immunoglobulin A[10.2174:2211556006666170525161225] |
| Journal?of?Veterinary?Internal?Medicine | FRIDAY, NOVEMBER 3, 2017 11.30-12.0 BALLROOM AB[:] |
| Universal Journal of Pharmaceutical Research | SEROPREVALENCE OF ANTI-MANNOSE BINDING LECTIN AUTOANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SANA'A CITY-YEMEN[10.22270:ujpr.v3i2.138] |
| Involvement of RBP4 in diabetic atherosclerosis and the role of vitamin D intervention[:] | |
| Clin Oral Investig.? | Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis[Pubmed:29713888] |
| Myocardial fibrosis in hypertrophic cardiomyopathy[:] | |
| TELLING TRANSVERSAL COMPETENCES… TO BE PROFESSIONALLY PROMOTED[:] | |
| Protein biomarker panels for detecting colorectal cancer and advanced adenoma[:] | |
| Endothelotropic activity of 4-hydroxy-3, 5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia[:] | |
| Silencing of the CSNK2β gene by siRNA inhibits invasiveness and growth of MDA-MB-231 cells[10.1101:311092] | |
| Duchenne Muscular Dystrophy | Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes Is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy[Pubmed:29067667] |
| S | S[S] |
| P | P[P] |
| D | D[D] |
| h | h[h] |
| O | O[O] |
| M | M[M] |
| E | E[E] |
| I | I[I] |
| B | B[B] |
| T | T[T] |
| N | N[N] |
| [] | |
| [] | |
| L | L[L] |
| J | J[J] |
| Journal of Geriatric?Oncology | Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors[Pubmed: 30952517] |
| clinica chimica acta | The performances of serum activins and follistatin in the diagnosis of ectopic pregnancy: A prospective case-control study[Pubmed: 31647905] |
| hindawi | The Association between the Activin A Serum Level and Carotid Intima-Media Thickness in Chronic Kidney Disease Patients[] |
| Pathology & Oncology Research | Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status[34867090] |